Literature DB >> 9814486

11Beta-hydroxysteroid dehydrogenase type 2 in human lung: possible regulator of mineralocorticoid action.

T Suzuki1, H Sasano, S Suzuki, G Hirasawa, J Takeyama, Y Muramatsu, F Date, H Nagura, Z S Krozowski.   

Abstract

11Beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) catalyzes the conversion of cortisol to biologically inactive cortisone and is thought to confer specificity on mineralocorticoid receptors (MR). Cortisol is a prerequisite for surfactant synthesis and fetal lung maturation. Recently, expression of 11betaHSD2 was demonstrated in human fetal lung, but its localization and possible biological roles remain unknown. Therefore, in this study, we examined immunohistochemical localization of 11betaHSD2, MR, and glucocorticoid receptor (GR) in nonpathological human lungs from fetus to adult (8 weeks gestation to 55 yr of age; n = 40) retrieved from pathology files. Both 11betaHSD2 and MR immunoreactivities were detected in airway epithelia, from bronchiole to trachea and in fetal and neonatal ciliated collecting duct cells of tracheal and bronchial glands, but were undetectable in alveoli. On the other hand, GR was detected in all cell types. These results indicate that 11betaHSD2 colocalizes with MR in human airway epithelia and suggest that 11betaHSD2 play an important role in pulmonary mineralocorticoid activity such as sodium and fluid transport.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814486     DOI: 10.1210/jcem.83.11.5227

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  IL-13-induced changes in endogenous glucocorticoid metabolism in the lung regulate the proasthmatic response.

Authors:  Maureen B Josephson; Junfang Jiao; Shuyun Xu; Aihua Hu; Chinmay Paranjape; Judith S Grunstein; Yael Grumbach; Gustavo Nino; Portia A Kreiger; Joseph McDonough; Michael M Grunstein
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-06       Impact factor: 5.464

2.  Immunohistochemical analysis of 11-beta-hydroxysteroid dehydrogenase type 2 and glucocorticoid receptor in subclinical Cushing's disease due to pituitary macroadenoma.

Authors:  Takanori Ebisawa; Katsuyoshi Tojo; Naoko Tajima; Masami Kamio; Yutaka Oki; Katsuhiko Ono; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 3.  Regulation of epithelial sodium channel trafficking by ubiquitination.

Authors:  Douglas C Eaton; Bela Malik; Hui-Fang Bao; Ling Yu; Lucky Jain
Journal:  Proc Am Thorac Soc       Date:  2010-02

4.  Serum cortisol and cortisone levels in newborns with congenital adrenal hyperplasia before the start of therapy.

Authors:  J Dötsch; I Hohenberger; F G Riepe; W G Sippell; H G Dörr
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

Review 5.  Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Authors:  Milla Marques Hermidorff; Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

Review 6.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

7.  Glucocorticoid Induced Cerebellar Toxicity in the Developing Neonate: Implications for Glucocorticoid Therapy during Bronchopulmonary Dysplasia.

Authors:  Kevin K Noguchi
Journal:  Cells       Date:  2014-01-08       Impact factor: 6.600

8.  Anti-inflammatory effects of levalbuterol-induced 11β-hydroxysteroid dehydrogenase type 1 activity in airway epithelial cells.

Authors:  Matthew J Randall; Shannon F Kostin; Edward J Burgess; Laura R Hoyt; Jennifer L Ather; Lennart K Lundblad; Matthew E Poynter
Journal:  Front Endocrinol (Lausanne)       Date:  2015-01-12       Impact factor: 5.555

9.  Ontogeny of adrenal-like glucocorticoid synthesis pathway and of 20α-hydroxysteroid dehydrogenase in the mouse lung.

Authors:  Eric Boucher; Pierre R Provost; Yves Tremblay
Journal:  BMC Res Notes       Date:  2014-03-01

10.  11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma.

Authors:  Ryoko Saito; Yasuhiro Miki; Takuto Abe; Eisaku Miyauchi; Jiro Abe; Ren Nanamiya; Chihiro Inoue; Ikuro Sato; Hironobu Sasano
Journal:  Br J Cancer       Date:  2020-04-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.